263 related articles for article (PubMed ID: 27128030)
1. Maternal Use of Selective Serotonin Reuptake Inhibitors and Lengthening of the Umbilical Cord: Indirect Evidence of Increased Foetal Activity-A Retrospective Cohort Study.
Kivistö J; Lehto SM; Halonen K; Georgiadis L; Heinonen S
PLoS One; 2016; 11(4):e0154628. PubMed ID: 27128030
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.
Lund N; Pedersen LH; Henriksen TB
Arch Pediatr Adolesc Med; 2009 Oct; 163(10):949-54. PubMed ID: 19805715
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
Eke AC; Saccone G; Berghella V
BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
[TBL] [Abstract][Full Text] [Related]
5. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.
Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT
Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451
[TBL] [Abstract][Full Text] [Related]
6. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
7. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.
Nezvalová-Henriksen K; Spigset O; Brandlistuen RE; Ystrom E; Koren G; Nordeng H
Int J Epidemiol; 2016 Dec; 45(6):2018-2029. PubMed ID: 27188860
[TBL] [Abstract][Full Text] [Related]
8. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
[TBL] [Abstract][Full Text] [Related]
9. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
Laine K; Heikkinen T; Ekblad U; Kero P
Arch Gen Psychiatry; 2003 Jul; 60(7):720-6. PubMed ID: 12860776
[TBL] [Abstract][Full Text] [Related]
10. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
Grzeskowiak LE; Gilbert AL; Morrison JL
J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
[TBL] [Abstract][Full Text] [Related]
11. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
[TBL] [Abstract][Full Text] [Related]
12. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
van der Veere CN; Bos AF
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Maternal Depression, Antidepressant Use During Pregnancy, and Adverse Pregnancy Outcomes: An Individual Participant Data Meta-analysis.
Vlenterie R; van Gelder MMHJ; Anderson HR; Andersson L; Broekman BFP; Dubnov-Raz G; El Marroun H; Ferreira E; Fransson E; van der Heijden FMMA; Holzman CB; Kim JJ; Khashan AS; Kirkwood BR; Kuijpers HJH; Lahti-Pulkkinen M; Mason D; Misra D; Niemi M; Nordeng HME; Peacock JL; Pickett KE; Prady SL; Premji SS; Räikkönen K; Rubertsson C; Sahingoz M; Shaikh K; Silver RK; Slaughter-Acey J; Soremekun S; Stein DJ; Sundström-Poromaa I; Sutter-Dallay AL; Tiemeier H; Uguz F; Varela P; Vrijkotte TGM; Winterfeld U; Zar HJ; Zervas IM; Prins JB; Pop-Purceleanu M; Roeleveld N
Obstet Gynecol; 2021 Oct; 138(4):633-646. PubMed ID: 34623076
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy.
Non AL; Binder AM; Kubzansky LD; Michels KB
Epigenetics; 2014 Jul; 9(7):964-72. PubMed ID: 24751725
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study.
Lindqvist PG; Nasiell J; Gustafsson LL; Nordstrom L
J Thromb Haemost; 2014 Dec; 12(12):1986-92. PubMed ID: 25322909
[TBL] [Abstract][Full Text] [Related]
16. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
[TBL] [Abstract][Full Text] [Related]
18. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
[TBL] [Abstract][Full Text] [Related]
19. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
[TBL] [Abstract][Full Text] [Related]
20. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]